Eli Lilly’s antibody treatment gets emergency FDA approval

The decision, announced Monday by the agency, is likely to be seen as a valuable tool to treat patients with COVID-19 at a time when the pandemic is raging across the United States, hospitals are overwhelmed and doctors have few options to treat the disease.